Search

Ardin H. Marschel

Examiner (ID: 15670)

Most Active Art Unit
1631
Art Unit(s)
1634, 1635, 1655, 1744, 1614, 1803, 1631, 1637, 1636, 2899, 1809, 1611, 1807
Total Applications
1516
Issued Applications
761
Pending Applications
308
Abandoned Applications
447

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7527472 [patent_doc_number] => 08044064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Fused pyrrolocarbazoles' [patent_app_type] => utility [patent_app_number] => 12/708306 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41797 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044064.pdf [firstpage_image] =>[orig_patent_app_number] => 12708306 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/708306
Fused pyrrolocarbazoles Feb 17, 2010 Issued
Array ( [id] => 6569994 [patent_doc_number] => 20100234472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'NITRIC OXIDE RELEASING DERIVATIVES OF PARACETAMOL' [patent_app_type] => utility [patent_app_number] => 12/707410 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8253 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234472.pdf [firstpage_image] =>[orig_patent_app_number] => 12707410 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/707410
Nitric oxide releasing derivatives of paracetamol Feb 16, 2010 Issued
Array ( [id] => 4432343 [patent_doc_number] => 07968589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 12/702358 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23373 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968589.pdf [firstpage_image] =>[orig_patent_app_number] => 12702358 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/702358
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Feb 8, 2010 Issued
Array ( [id] => 6289382 [patent_doc_number] => 20100158798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'FP-Pocket-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity' [patent_app_type] => utility [patent_app_number] => 12/701947 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17546 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158798.pdf [firstpage_image] =>[orig_patent_app_number] => 12701947 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/701947
FP-pocket-binding effectors and methods for using the same to modulate telomerase activity Feb 7, 2010 Issued
Array ( [id] => 8104049 [patent_doc_number] => 08153673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Metalloproteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/693852 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14817 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153673.pdf [firstpage_image] =>[orig_patent_app_number] => 12693852 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/693852
Metalloproteinase inhibitors Jan 25, 2010 Issued
Array ( [id] => 6388838 [patent_doc_number] => 20100317710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => '3-(3-INDOLYL) PROPIONIC ACID CALCIUM SALT AND METHOD OF MAKING 3-(3-INDOLYL) PROPIONIC ACID FREE ACID THEREFROM' [patent_app_type] => utility [patent_app_number] => 12/691067 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317710.pdf [firstpage_image] =>[orig_patent_app_number] => 12691067 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/691067
3-(3-INDOLYL) PROPIONIC ACID CALCIUM SALT AND METHOD OF MAKING 3-(3-INDOLYL) PROPIONIC ACID FREE ACID THEREFROM Jan 20, 2010 Abandoned
Array ( [id] => 8533581 [patent_doc_number] => 08309738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Methods for the preparation of thiazolidinethione indene-based chiral auxiliaries' [patent_app_type] => utility [patent_app_number] => 12/685014 [patent_app_country] => US [patent_app_date] => 2010-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7683 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12685014 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/685014
Methods for the preparation of thiazolidinethione indene-based chiral auxiliaries Jan 10, 2010 Issued
Array ( [id] => 7511516 [patent_doc_number] => 20110257226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'HALOGEN-CONTAINING ORGANOSULFUR COMPOUND AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/141643 [patent_app_country] => US [patent_app_date] => 2009-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44967 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257226.pdf [firstpage_image] =>[orig_patent_app_number] => 13141643 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/141643
Halogen-containing organosulfur compound and use thereof Dec 23, 2009 Issued
Array ( [id] => 8630194 [patent_doc_number] => 08362266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Method of manufacturing a ruthenium complex' [patent_app_type] => utility [patent_app_number] => 12/636025 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2213 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12636025 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/636025
Method of manufacturing a ruthenium complex Dec 10, 2009 Issued
Array ( [id] => 4432744 [patent_doc_number] => 07968730 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Synthesis of amines and intermediates for the synthesis thereof' [patent_app_type] => utility [patent_app_number] => 12/631894 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23161 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968730.pdf [firstpage_image] =>[orig_patent_app_number] => 12631894 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/631894
Synthesis of amines and intermediates for the synthesis thereof Dec 6, 2009 Issued
Array ( [id] => 6592719 [patent_doc_number] => 20100130582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'INDOLINONE MODULATORS OF DOPAMINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/624618 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11068 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130582.pdf [firstpage_image] =>[orig_patent_app_number] => 12624618 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/624618
INDOLINONE MODULATORS OF DOPAMINE RECEPTOR Nov 23, 2009 Abandoned
Array ( [id] => 4599947 [patent_doc_number] => 07977380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Inhibitors of plasma kallikrein' [patent_app_type] => utility [patent_app_number] => 12/623326 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14222 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977380.pdf [firstpage_image] =>[orig_patent_app_number] => 12623326 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/623326
Inhibitors of plasma kallikrein Nov 19, 2009 Issued
Array ( [id] => 7550706 [patent_doc_number] => 08063039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => '3-aminopyrrolidone derivatives' [patent_app_type] => utility [patent_app_number] => 12/610660 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8338 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063039.pdf [firstpage_image] =>[orig_patent_app_number] => 12610660 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/610660
3-aminopyrrolidone derivatives Nov 1, 2009 Issued
Array ( [id] => 7545023 [patent_doc_number] => 08052993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => '3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)' [patent_app_type] => utility [patent_app_number] => 12/607291 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7695 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/052/08052993.pdf [firstpage_image] =>[orig_patent_app_number] => 12607291 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/607291
3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) Oct 27, 2009 Issued
Array ( [id] => 6578492 [patent_doc_number] => 20100047347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => '3\'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2\'-hydroxy-[1,1\'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)' [patent_app_type] => utility [patent_app_number] => 12/607320 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7696 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047347.pdf [firstpage_image] =>[orig_patent_app_number] => 12607320 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/607320
3′-[(2Z)-[1-(3,4-dimethylphenyl)-1 ,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) Oct 27, 2009 Issued
Array ( [id] => 6468259 [patent_doc_number] => 20100040683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => '3\'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2\'-hydroxy-[1,1\'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)' [patent_app_type] => utility [patent_app_number] => 12/607284 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7696 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040683.pdf [firstpage_image] =>[orig_patent_app_number] => 12607284 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/607284
3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) Oct 27, 2009 Issued
Array ( [id] => 7545024 [patent_doc_number] => 08052994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => '3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)' [patent_app_type] => utility [patent_app_number] => 12/607305 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7695 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/052/08052994.pdf [firstpage_image] =>[orig_patent_app_number] => 12607305 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/607305
3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) Oct 27, 2009 Issued
Array ( [id] => 7545025 [patent_doc_number] => 08052995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => '3\'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2\'-hydroxy-[1,1\'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)' [patent_app_type] => utility [patent_app_number] => 12/607330 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7695 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/052/08052995.pdf [firstpage_image] =>[orig_patent_app_number] => 12607330 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/607330
3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) Oct 27, 2009 Issued
Array ( [id] => 6280949 [patent_doc_number] => 20100119623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'IMIDAZOLYL MODULATORS OF 5-HT3 RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/560939 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11914 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119623.pdf [firstpage_image] =>[orig_patent_app_number] => 12560939 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/560939
IMIDAZOLYL MODULATORS OF 5-HT3 RECEPTORS Sep 15, 2009 Abandoned
Array ( [id] => 6479094 [patent_doc_number] => 20100041707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'INHIBITORS OF ION CHANNELS' [patent_app_type] => utility [patent_app_number] => 12/561002 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18756 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041707.pdf [firstpage_image] =>[orig_patent_app_number] => 12561002 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/561002
Inhibitors of ion channels Sep 15, 2009 Issued
Menu